Having trouble accessing articles? Reset your cache.

Convergence launches with $35.4 million

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) spun out Convergence Pharmaceuticals Ltd. (Cambridge, U.K.), which raised $35.4 million in a

Read the full 176 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE